168 THIRD AVENUE, WALTHAM, MA
To Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
Reports Third Quarter 2025 Results
News, Underwriting Agreement, Securities Holder Rights or Indentures, Legal Opinion
Completes Acquisition of Solventum’s Purification and Filtration Business
Changes in Board, Management or Compensation
Reports Second Quarter 2025 Results
Shareholder votes
News, Material Contracts
Q3
Q2
FY 2023
Q1
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Free Writing Prospectus
Specialized Disclosure Report
Amended Notice of Proposed Sale of Securities
Amended Tender Offer Statement by Third Party